WZH-17-002

WZH-17-002 is a WZH-15-125-based ALK PROTAC degrader with a DC50 of 25 nM. WZH-17-002 enhances activities against Lorlatinib (HY-12215)-resistant ALK compound mutations. WZH-17-002 significantly reduces drug resistance in ALK-fusion non-small cell lung cancer (NSCLC) and inhibits tumor growth in EML4-ALK G1202R/L1196 M xenograft mice model. Pink: ALK ligand (HY-174314); Blue: CRBN ligase ligand (HY-14658); Black: linker (HY-174316)
(Pink: Anaplastic lymphoma kinase (ALK) ligand (HY-174314); Blue: Cereblon ligand (HY-14658); Black: linker (HY-174316)).

For research use only. We do not sell to patients.

  • Formula: C47H54BrN11O10S
  • Molecular Weight:1044.97
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

All Akt Isoforms

More

All ERK Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00